Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Quotes 5-day view
Real-time Euronext Bruxelles2024-05-29 | 2024-05-30 | 2024-05-31 | 2024-06-03 | |
---|---|---|---|---|
Last | 11.7 € | 11.7 € | 11.7 € | 11.7 € |
Change | -.--% | -.--% | -.--% | -.--% |
Performance
1 day | -1.27% | ||
3 months | -5.26% | ||
6 months | -6.02% | ||
Current year | -8.24% | ||
1 year | -0.85% | ||
3 years | -16.13% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.27% | -.--% | -8.24% | -0.85% | 355M | ||
+1.33% | +2.95% | +42.60% | +87.93% | 739B | ||
-0.37% | +0.46% | +32.34% | +70.93% | 598B | ||
+0.73% | +0.52% | -5.74% | -5.88% | 353B | ||
+2.29% | -0.83% | +17.79% | +14.13% | 318B | ||
-0.65% | +1.99% | +3.37% | +17.04% | 285B | ||
+1.28% | +0.41% | +16.47% | +5.09% | 240B | ||
-0.47% | +0.76% | +9.26% | +3.76% | 210B | ||
+0.48% | +0.96% | -5.07% | -20.73% | 206B | ||
+0.51% | +0.52% | +6.74% | +40.97% | 164B | ||
+2.27% | +1.49% | +1.81% | -23.59% | 162B | ||
+0.39% | +0.28% | +0.39% | -5.13% | 122B | ||
-9.54% | -9.95% | +10.19% | +16.85% | 91.66B | ||
+1.65% | +1.29% | -18.59% | -36.38% | 83.29B | ||
-1.31% | -3.43% | -21.70% | -18.56% | 80.07B | ||
-0.35% | -1.07% | +40.39% | +13.04% | 68.01B | ||
Average | -0.28% | -0.20% | +7.63% | +9.91% | ||
Weighted average by Cap. | +0.21% | +0.67% | +16.69% | +30.25% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -8.24% | ||
2023 | +9.91% | ||
2022 | -32.95% | ||
2021 | +82.11% | ||
2020 | -8.57% |
- Stock Market
- Equities
- HYL Stock
- Quotes Hyloris Pharmaceuticals SA